Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.092 AUD | -2.13% | -6.12% | +318.18% |
04-30 | Nyrada's NYR-BI03 Being Studied For Potential in Traumatic Brain Injury | MT |
04-18 | Transcript : Nyrada Inc., Q3 2024 Earnings Call, Apr 18, 2024 |
Sales 2022 | 1.09 1.69 1.51 | Sales 2023 | 1.43 2.21 1.97 | Capitalization | 4.37M 6.74M 6.02M |
---|---|---|---|---|---|
Net income 2022 | -3M -4.63M -4.13M | Net income 2023 | -7M -10.81M -9.64M | EV / Sales 2022 | 9,367,032 x |
Net cash position 2022 | 10.82M 16.7M 14.9M | Net cash position 2023 | 3.71M 5.73M 5.11M | EV / Sales 2023 | 461,207 x |
P/E ratio 2022 |
-4.5
x | P/E ratio 2023 |
-0.56
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 30.03% |
Latest transcript on Nyrada Inc.
1 day | -2.13% | ||
1 week | -6.12% | ||
Current month | -7.07% | ||
1 month | +1.10% | ||
3 months | +318.18% | ||
6 months | +318.18% | ||
Current year | +318.18% |
Managers | Title | Age | Since |
---|---|---|---|
James Bonnar
CEO | Chief Executive Officer | - | 18-01-31 |
Founder | - | 17-08-28 | |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 17-08-28 | |
Ruediger Weseloh
BRD | Director/Board Member | - | 19-05-31 |
Marcus Frampton
BRD | Director/Board Member | 44 | 19-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 0.092 | -2.13% | 408 496 |
24-04-30 | 0.094 | -1.05% | 618,536 |
24-04-29 | 0.095 | +1.06% | 558,347 |
24-04-26 | 0.094 | -2.08% | 1,351,825 |
24-04-24 | 0.096 | -2.04% | 321,445 |
Delayed Quote Australian S.E., May 01, 2024 at 02:10 am
More quotes1st Jan change | Capi. | |
---|---|---|
+318.18% | 10.95M | |
+34.00% | 704B | |
+25.80% | 577B | |
-7.75% | 348B | |
+18.53% | 327B | |
+4.95% | 288B | |
+15.21% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.89% | 147B |
- Stock Market
- Equities
- NYR Stock